Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Blood Advances
|
April 25, 2018
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Blood Advances
|
July 25, 2018
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
Maximilian Stahl, Michelle DeVeaux, Theo de Witte, et al.
Haematologica
|
April 4, 2020
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Ali Bazarbachi, Gesine Bug, Frederic Baron, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 13, 2018
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
The Lancet. Haematology
|
November 12, 2022
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
Justin M Watts, Maria R Baer, Jay Yang, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
International Journal of Molecular Sciences
|
April 20, 2017
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Antonio M Almeida, Thomas Prebet, Raphael Itzykson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021
Daniel A Pollyea, Dale Bixby, Alexander Perl, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 15, 2019
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Martin S Tallman, Eunice S Wang, Jessica K Altman, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Blood Advances
|
April 25, 2018
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Blood Advances
|
July 25, 2018
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
Maximilian Stahl, Michelle DeVeaux, Theo de Witte, et al.
Haematologica
|
April 4, 2020
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Ali Bazarbachi, Gesine Bug, Frederic Baron, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 13, 2018
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
The Lancet. Haematology
|
November 12, 2022
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
Justin M Watts, Maria R Baer, Jay Yang, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
International Journal of Molecular Sciences
|
April 20, 2017
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Antonio M Almeida, Thomas Prebet, Raphael Itzykson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021
Daniel A Pollyea, Dale Bixby, Alexander Perl, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 15, 2019
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Martin S Tallman, Eunice S Wang, Jessica K Altman, et al.
Page
of 10